Cynthia Wright, MD
Gastroenterology · Flowood, MSNPI 1417945668
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 271 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 35.9% of the total. Reporting peaked in 2019 at $775 and has fallen 60.9% since, to $303 in 2025. That places this record below the midpoint for gastroenterology clinicians in MS, where the typical reported total is $3,928.
Across 271 payments — averaging $14.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$927
- Takeda Pharmaceuticals U.S.A., Inc.$426
- Bristol Myers Squibb$256
- Pfizer$196
- Intercept Pharmaceuticals, Inc.$120
- plus $600 from 14 others
What the payments were for
- Food & beverage$3,938100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 100 | $1,413 |
| AbbVie(2 entities) | 59 | $927 |
| Takeda Pharmaceuticals U.S.A., Inc. | 32 | $426 |
| Bristol Myers Squibb | 22 | $256 |
| Pfizer | 17 | $196 |
| Intercept Pharmaceuticals, Inc. | 8 | $120 |
| Regeneron Healthcare Solutions, Inc. | 5 | $97 |
| Sanofi | 3 | $75 |
| Phathom Pharmaceuticals, Inc. | 4 | $75 |
| Ardelyx, Inc. | 4 | $64 |
| Ironwood Pharmaceuticals, Inc | 3 | $55 |
| Ipsen Biopharmaceuticals, Inc | 3 | $48 |
| Nestle Healthcare Nutrition Inc. | 2 | $37 |
| Braintree Laboratories, Inc. | 1 | $31 |
| Merck | 2 | $30 |
| Shire North American Group Inc | 2 | $25 |
| Redhill Biopharma Inc. | 1 | $23 |
| AstraZeneca | 1 | $13 |
| Evoke Pharma, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
How this compares
$3,938 in reported general payments places this provider in the 50th percentile of 127 gastroenterology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 53 | $49,068 |
| XifaxanRifaximin | 13 | $25,280 |
| TrulancePlecanatide | 24 | $16,268 |
| CreonLipase/Protease/Amylase | 13 | $14,732 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 75 | $11,923 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 79 | $10,706 |
| Colesevelam Hcl | 51 | $8,893 |
| Dexlansoprazole DrDexlansoprazole | 24 | $6,015 |
| Balsalazide Disodium | 16 | $4,986 |
| Sucralfate | 80 | $4,861 |
| Mesalamine | 17 | $4,845 |
| Omeprazole | 429 | $4,086 |
| Famotidine | 319 | $3,123 |
| Pantoprazole Sodium | 238 | $2,668 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 16 | $2,594 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $927 | $63,80166 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance, Plenvu | $1,413 | $52,254116 claims |
| Braintree Laboratories, Inc.Sutab | $31 | $2,59416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 127 gastroenterology providers in Mississippi.
Other gastroenterology in Flowood
- Reed HoganFlowood$216K
- Vonda ReevesFlowood$39K
- Reed HoganFlowood$35K
- Jane Claire WilliamsFlowood$16K
- Ronald KotfilaFlowood$10K
- Stewart BoydFlowood$4K
- Wassem JuakiemBiloxi$519K
- John PhillipsTupelo$150K
- Brian BorgJackson$68K
- Pegah Hosseini-CarrollJackson$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.